Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases

BACKGROUND: The pathological tumor burden score (TBS) has been proven to be a better risk stratification tool for liver metastasis of colorectal cancer than the traditional clinical risk score (CRS). The aim of this study was to evaluate the prognostic value of the pathological tumor burden score in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Leen, Sun, Hui, He, Jiahua, Liu, Yujun, Pan, Zhizhong, Wu, Xiaojun, Fan, Wenhua, Peng, Jianhong, Li, Cong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492270/
https://www.ncbi.nlm.nih.gov/pubmed/37689651
http://dx.doi.org/10.1186/s12893-023-02145-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492270/
https://www.ncbi.nlm.nih.gov/pubmed/37689651
http://dx.doi.org/10.1186/s12893-023-02145-w

Ejemplares similares